Unknown

Dataset Information

0

Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.


ABSTRACT:

Introduction

Blood-based Alzheimer's disease (AD) biomarkers provide opportunities for community studies and across ethnic groups. We investigated blood biomarker concentrations in the Washington Heights-Inwood Columbia Aging Project (WHICAP), a multi-ethnic community study of aging and dementia.

Methods

We measured plasma amyloid beta (Aβ)40, Aβ42, total tau (t-tau), phosphorylated tau (p-tau)181, and p-tau217, and neurofilament light chain (NfL) in 113 autopsied participants (29% with high AD neuropathological changes) and in 300 clinically evaluated individuals (42% with clinical AD). Receiver operating characteristics were used to evaluate each biomarker. We also investigated biomarkers as predictors of incident clinical AD.

Results

P-tau181, p-tau217, and NfL concentrations were elevated in pathologically and clinically diagnosed AD. Decreased Aβ42/Aβ40 ratio and increased p-tau217 and p-tau181 were associated with subsequent AD diagnosis.

Discussion

Blood-based AD biomarker concentrations are associated with pathological and clinical diagnoses and can predict future development of clinical AD, providing evidence that they can be incorporated into multi-ethnic, community-based studies.

SUBMITTER: Brickman AM 

PROVIDER: S-EPMC8451860 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7125218 | biostudies-literature
| S-EPMC7818141 | biostudies-literature
| S-EPMC7880671 | biostudies-literature
| S-EPMC7101073 | biostudies-literature
| S-EPMC9082389 | biostudies-literature
| S-EPMC7612227 | biostudies-literature
| S-EPMC8645090 | biostudies-literature
| S-EPMC10387518 | biostudies-literature
| S-EPMC9610280 | biostudies-literature
| S-EPMC9499867 | biostudies-literature